Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Zofran and Kytril False Claims Act Violations

GlaxoSmithKline paid over $150 million to settle allegations that it violated the False Claims Act through the fraudulent drug pricing and marketing of the anti-emetic drugs Zofran and Kytril. GSK allegedly engaged in a scheme to set and maintain inflated prices for Zofran and Kytril knowing that federal healthcare programs established reimbursement rates based on those prices, and thereby caused false and fraudulent claims to be submitted to Medicare and other federal healthcare programs. The government also alleged GSK engaged in a “double dipping” billing scheme with respect to Kytril by encouraging customers to pool leftover vials of Kytril to create an extra dose, which would then be administered to a patient and re-billed to government healthcare programs.

Misconduct Type
Defective Pricing
Enforcement Agency
Health and Human Services
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Press Release
9/20/2005
Contractors Involved Penalty
Total
GlaxoSmithKline $150,000,000
Further Information Released
DOJ Press Release 8/24/2007

Federal Contractor Misconduct Database